References
- Bipartisan report of the Blue Ribbon study panel in Biodefense. 2015 Oct. Available from: http://www.potomacinstitute.org/images/ICTS/BlueRibbonreportFINAL.pdf
- Moon S, Sridhar D, Pate MA, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM independent panel on the global response to Ebola. Lancet. 2015 28;386(10009):2204–2221.
- De Groot AS, Einck L, Moise L, et al. Making vaccines “on demand”: a potential solution for emerging pathogens and biodefense? Hum Vaccin Immunother. 2013;9(9):1877–1884.
- Moise L, Gutierrez A, Kibria F, et al. iVAX: an integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Hum Vaccin Immunother. 2015;11(9):2312–2321.
- De Groot AS. Testimony of Dr. Annie De Groot before the Blue Ribbon Study Panel on Biodefense. 2015 Apr 1. Available from: http://www.epivax.com/wp-content/uploads/2015/04/EpiVax-De_Groot_testimony_Biodefense_Blue_Ribbon_Panel_01Apr2015G.pdf
- Katoski SE, Meyer H, Ibrahim S. An approach for identification of unknown viruses using sequencing-by-hybridization. J Med Virol. 2015 Sep;87(9):1616–1624.
- Gardner SN, Frey KG, Redden CL, et al. Targeted amplification for enhanced detection of biothreat agents by next-generation sequencing. BMC Res Notes. 2015;8(1):682.
- Gilchrist CA, Turner SD, Riley MF, et al. Whole-genome sequencing in outbreak analysis. Microbiol Rev. 2015 Jul;28(3):541–563. doi:10.1128/CMR.00075−13.
- Rizvi NA, Hellmann MD, Snyder A, et al. Mutational landscape determines sensitivity to PD−1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124–128.
- Seib KL, Dougan G, Rappuoli R. The key role of genomics in modern vaccine and drug design for emerging infectious diseases. PLoS Genet. 2009;5(10):e1000612.
- De Groot AS, Ardito M, Terry F, et al. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Hum Vaccin Immunother. 2013;9(5):950–956.
- Soria-Guerra RE, Nieto-Gomez R, Govea-Alonso DO, et al. An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J Biomed Inform. 2015;53:405–414.
- Leblanc P, Moise L, Luza C, et al. VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever. Hum Vaccin Immunother. 2014;10(10):3022–3038.
- Reardon S. US biodefence facilities ramp up. Government effort to produce vaccines on demand raises questions about cost and strategy. Nature. 2014;509:16–17.
- Gaucher D, Therrien R, Kettaf N, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med. 2008;205(13):3119–3131.
- Higbee RG, Byers AM, Dhir V, et al. An immunologic model for rapid vaccine assessment – a clinical trial in a test tube. Altern Lab Anim. 2009;37(Suppl 1):19–27.
- Liu R, Moise L, Tassone R, et al. H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance. Hum Vaccin Immunother. 2015;11(9):2241–2252.
- Losikoff PT, Mishra S, Terry F, et al. HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. J Hepatol. 2015;62(1):48–55.
- Bresciani A, Paul S, Schommer N, et al. T cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome. Immunology. 2016;148:34–39.
- Wullner D, Zhou L, Bramhall E. Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics. Clin Immunol. 2010;137(1):5–14.
- Product Development Under the Animal Rule. 2015. Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM399217.pdf
- Graham B, Talent J. Graham Allison et al. World at risk. The Report of the Commission on the Prevention of WMD Proliferation and Terrorism. Vintage books. 2008. Available from: http://www.pharmathene.com/World_at_Risk_Report.pdf
- Graham B, Talent J. Prevention of WMD Proliferation and Terrorism Report Card. 2010. Available from: http://www.pharmathene.com/WMD_Report_Card.pdf